The genetic programmes activated in drug‐resistant mesenchymal‐like melanoma cells share common features with EMT, including increased TGFβ signalling and high levels of AXL (Rambow et al, 2018; Arozarena & Wellbrock, 2019; Pedri et al, 2021). Here, TGFB1 is linked to melanoma.